Auteurs
Analysis
UK
Racine
Analysis
UK
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Analysis (UK)

Index « Auteurs » - entrée « Anthony H. V. Schapira »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Anthony H. Schapira < Anthony H. V. Schapira < Anthony Hv Schapira  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
000116 (2014) Rubén G Mez-Sánchez [Espagne] ; Matthew E. Gegg [Royaume-Uni] ; José M. Bravo-San Pedro [Espagne, France] ; Mireia Niso-Santano [Espagne, France] ; Lydia Alvarez-Erviti [Royaume-Uni] ; Elisa Pizarro-Estrella [Espagne] ; Yolanda Gutiérrez-Martín [Espagne] ; Alberto Alvarez-Barrientos [Espagne] ; José M. Fuentes [Espagne] ; Rosa Ana González-Polo [Espagne] ; Anthony H. V. Schapira [Royaume-Uni]Mitochondrial impairment increases FL-PINK1 levels by calcium-dependent gene expression☆
000140 (2014) Anthony H. V. Schapira [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; J. Timothy Greenamyre [États-Unis] ; Erwan Bezard [France]Movement disorders 3: Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives
000170 (2013) Ruth-Mary Desouza [Royaume-Uni] ; Elena Moro [France] ; Anthony E. Lang [Canada] ; Anthony H. V. Schapira [Royaume-Uni]Timing of deep brain stimulation in Parkinson disease: A need for reappraisal?
000317 (2010) Matthew E. Gegg [Royaume-Uni] ; J. Mark Cooper [Royaume-Uni] ; Kai-Yin Chau [Royaume-Uni] ; Manuel Rojo [France] ; Anthony H. V. Schapira [Royaume-Uni] ; Jan-Willem Taanman [Royaume-Uni]Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy
000333 (2010) Anthony H. V. Schapira [Royaume-Uni] ; Stefan Albrecht [Allemagne] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis]Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study
000334 (2010) Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche]Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
000342 (2010) Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France]Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease
000464 (2006) Anthony H. V. Schapira [Royaume-Uni] ; Erwan Bezard [France] ; Jonathan Brotchie [Canada] ; Frdric Calon [Canada] ; Graham L. Collingridge [Royaume-Uni] ; Borris Ferger [Allemagne] ; Bastian Hengerer [Allemagne] ; Etienne Hirsch [France] ; Peter Jenner [Royaume-Uni] ; Nicolas Le Novre [Royaume-Uni] ; Jos A. Obeso [Espagne] ; Michael A. Schwarzschild [États-Unis] ; Umberto Spampinato [France] ; Giora Davidai [États-Unis]Novel pharmacological targets for the treatment of Parkinson's disease
000601 (2000) C. Warren Olanow [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France]Continuous dopamine-receptor stimulation in early Parkinson's disease

List of associated KwdEn.i

Nombre de
documents		Descripteur
5Parkinson disease
3Nervous system diseases
3Parkinson's disease
3Pramipexole
3Treatment
2Dopamine agonist
2Humans
2Release
2dopamine agonist
1Aged
1Antiparkinson Agents (administration & dosage)
1Antiparkinson Agents (adverse effects)
1Antiparkinson agent
1Autophagy (drug effects)
1Benzothiazoles (administration & dosage)
1Benzothiazoles (adverse effects)
1Calcium (metabolism)
1Carbonyl Cyanide m-Chlorophenyl Hydrazone (toxicity)
1Catechol O-methyltransferase
1Cell Line, Tumor
1Chemotherapy
1Confidence Intervals
1Delayed-Action Preparations (therapeutic use)
1Dopamine
1Dopamine receptor
1Dopaminergic transmission
1Dose-Response Relationship, Drug
1Double-Blind Method
1Drug Administration Schedule
1Dyskinesia
1Enzyme inhibitor
1Evaluation
1Female
1Gene Expression
1Genetics
1Huntington disease
1Induction
1Levodopa
1Male
1Medicine
1Middle Aged
1Mitochondria (drug effects)
1Mitochondria (enzymology)
1Mitochondria (metabolism)
1Mitochondrial Degradation (drug effects)
1Mitochondrial Degradation (physiology)
1Motion
1Motor system disorder
1Neuroblastoma (enzymology)
1Neuroblastoma (metabolism)
1Parkinson Disease (drug therapy)
1Perspective
1Protein Kinases (genetics)
1Protein Kinases (metabolism)
1Proto-Oncogene Proteins c-fos (metabolism)
1Proton Ionophores (toxicity)
1Review
1Safety
1Severity of Illness Index
1Time Factors
1Tumor suppressor gene
1clinical trial
1delayed‐start
1neuroprotection
1pramipexole
1pramipexole extended release
1pramipexole‐extended release
1switch trial
1treatment

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/UK/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i -k "Anthony H. V. Schapira" 

HfdIndexSelect -h $EXPLOR_AREA/Data/UK/Analysis/Author.i  \
                -Sk "Anthony H. V. Schapira" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/UK/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    UK
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Anthony H. V. Schapira
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024